Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics - Sesti, C; Simkhovich, B Z; Kalvinsh, I (J Cardiovasc Pharmacol, 2006)
et al.